APIXABAN CIPLA apixaban 5 mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

apixaban, Quantity: 5 mg

Disponible depuis:

Cipla Australia Pty Ltd

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; macrogol 400

Mode d'administration:

Oral

Unités en paquet:

10 tablets, 14 tablets, 28 tablets, 60 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

APIXABAN CIPLA is indicated for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective total hip or total knee replacement surgery.,APIXABAN CIPLA is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,APIXABAN CIPLA is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients.,APIXABAN CIPLA is indicated for the prevention of recurrent DVT and PE in adult patients.

Descriptif du produit:

Visual Identification: Pink, oval, bocinvex, film-coated tablet plain on both sides; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 10 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Registered